Analogic Corporation (NASDAQ:ALOG) Given Consensus Recommendation of "Hold" by Brokerages

Share

The shares were sold on May 15th for an average price of $73.60. Tower Research Llc (Trc) invested in 313 shares or 0% of the stock. James Patrick Ryan, See Remarks disclosed the sale of 180 shares of ALOG stock.

As of quarter end Macquarie Group Ltd had sold a total of 3,956 shares trimming its holdings by 22.5%.

Shares of Analogic Corporation (NASDAQ:ALOG) opened at 70.60 on Friday.

About 26,290 shares traded. Analogic Corporation has a 1-year low of $66.00 and a 1-year high of $95.85. The firm's market capitalization is $880.38 million. The stock has a 50-day moving average of $70.44 and a 200 day moving average of $73.94.

Analogic Corporation (NASDAQ:ALOG) last released its quarterly earnings data on Tuesday, June 6th.

'Game of Thrones': New Photos Tease Fallout From That Fiery Battle
After a thrilling and nerve racking The Spoils of War episode, the stills of the Eastwatch , the fifth episode has arrived. To really understand this, we're going to have to break down the two families involved: House Stark and House Targaryen .

As of the latest earnings report the EPS was $-3.29 and is expected to be $2.62 for the current year with 12,470,000 shares now outstanding. Analogic Corporation had a positive return on equity of 6.75% and a negative net margin of 7.97%. The business had revenue of $122.16 million for the quarter, compared to the consensus estimate of $121.35 million. Next quarter's EPS is estimated at $0.44 and the next full year EPS is anticipated to be $2.87. The firm's revenue for the quarter was down 4.5% compared to the same quarter a year ago. On average, equities research analysts predict that Analogic Corporation will post $2.62 EPS for the current year. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & global copyright and trademark laws. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. and global trademark and copyright law. The original version of this report can be accessed at https://www.themarketsdaily.com/2017/08/10/alliancebernstein-l-p-maintains-position-in-analogic-corporation-alog-updated-updated.html.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Stifel Financial Corp raised its position in Analogic Corporation by 9.8% in the first quarter. State of Alaska Department of Revenue now owns 1,380 shares of the medical research company's stock worth $104,000 after buying an additional 40 shares during the last quarter.

TIAA CREF Investment Management LLC reduced its stake in Analogic Corporation (NASDAQ:ALOG) by 4.0% during the first quarter, according to its most recent filing with the SEC. Goldman Sachs Group Inc bolstered its position by buying 1,087 shares an increase of 38.2% in the quarter. Finally, Independent Portfolio Consultants Inc. raised its stake in shares of Analogic Corporation by 6.1% in the first quarter.

Separately, Jefferies Group LLC started coverage on Analogic Corporation in a research note on Wednesday. The average 12-month target price among analysts that have issued ratings on the stock in the past year is $91.00. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. They issued a "hold" rating and a $75.00 price objective for the company.

The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Firm operates through three divisions: Medical Imaging, Ultrasound, and Security and Detection. The Company's Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Share